Memorial Sloan Kettering Cancer Center Amenity Kit
Sodium Monofluorophosphate
Search
59 matching records for CANCER.
NDC#
Fludeoxyglucose
Fludeoxyglucose F18
Fludeoxyglucose F 18
Fludeoxyglucose F 18
Sodium Fluoride F 18
Sodium Fluoride F 18
FLUDEOXYGLUCOSE F-18
FLUDEOXYGLUCOSE F-18
Cancer Council Daily Body Moisturizer SPF50 Plus
Avobenzone, Homosalate, Octisalate, Octocrylene
Cancer Council Protect and Hydrate Radiance SPF50 Plus
Avobenzone, Homosalate, Octisalate, Octocrylene
Cancer Council Invisible Fluid SPF50 Plus
Avobenzone, Homosalate, Octisalate, Octocrylene
Cancer Council Everyday Active SPF50 Plus
Avobenzone, Homosalate, Octisalate, Octocrylene
Cancer Council Daily Face Moisturizer SPF50
Avobenzone, Homosalate, Octisalate, Octocrylene
Cancer Council Mineral Fluid SPF50
Zinc Oxide
SOMA Anti-Cancergen
ASIAN GINSENG
Choline C 11
Choline C 11
John Wayne Cancer Foundation Mineral Sunscreen Facestick SPF 30
Sunscreen
Fludeoxyglucose F18
Fludeoxyglucose F18
Merci Handy Sanctuary Hand Sanitizer CANCER
ALCOHOL
DailyMed#
Cancer Council Daily Face Moisturizer SPF50
20260512
Cancer Council Invisible Fluid SPF50 Plus
20251203
Oncopig Cancer Model
20251013
Memorial Sloan Kettering Cancer Center Amenity Kit
20241217
Cancer Council Mineral Fluid SPF50
20241024
Cancer Council Everyday Active Gel SPF50 Plus
20240416
Cancer Council Protect and Hydrate Radiance SPF50 Plus
20240415
Cancer Council Daily Body Moisturizer SPF50 Plus
20240415
Merci Handy Sanctuary Hand Sanitizer CANCER
20221201
X3EMBrands, LLC John Wayne Cancer Foundation Mineral Sunscreen Facestick SPF 30
20211230
Fludeoxyglucose
2025-10-05
Choline C 11
2017-12-19
Axumin
2025-03-08
GMDN Terms#
Intraoperative tumour margin analyser
A mains electricity (AC-powered) unit designed for tissue surface analysis and characterization using radio-frequency (RF) spectroscopy, to identify cancerous tissue at the cut-lines (margins) during a lumpectomy procedure. It includes RF spectroscopy hardw...
Alternating electric field antimitotic cancer treatment system generator
A portable, battery-powered component of an alternating electric field cancer treatment system designed to generate intermediate-frequency (100-300 kHz) alternating electric current to treat certain forms of recurrent or newly-diagnosed cancer; typically gl...
Cryosurgical set
A sterile collection of disposable devices used in conjunction with a cryosurgical unit as well as monitoring and other devices to perform a surgical technique that involves freezing a targeted area of tissue to damage and destroy cancer cells in the unwant...
Cancer antigen 125 (CA125) IVD, antibody
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of cancer antigen 125 (CA125), a marker commonly associated with ovarian cancer, in a clinical sp...
Alternating electric field antimitotic cancer treatment system transducer array
A sterile, disposable, head-worn component of an alternating electric field cancer treatment system designed to convert intermediate-frequency (100-300 kHz) alternating electric current to low-intensity alternating electric fields to treat certain forms of ...
Cancer antigen 125 (CA125) IVD, kit, chemiluminescent immunoassay
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of cancer antigen 125 (CA125), a marker commonly associated with ovarian cancer, in a clinical specimen using a chemiluminescent im...
Cancer antigen 15-3 (CA15-3) IVD, kit, chemiluminescent immunoassay
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of cancer antigen 15-3 (CA15-3), a marker commonly associated with breast cancer, in a clinical specimen using a chemiluminescent i...
Cancer antigen 19-9 (CA19-9) IVD, kit, chemiluminescent immunoassay
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of cancer antigen 19-9 (CA19-9) in a clinical specimen, using a chemiluminescent immunoassay method. CA19-9 is typically used as a ...
Cancer antigen 15-3 (CA15-3) IVD, antibody
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of cancer antigen 15-3 (CA15-3), a marker commonly associated with breast cancer, in a clinical s...
Cancer antigen 15-3 (CA15-3) IVD, control
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of cancer antigen 15-3 (CA15-3), a marker commonly associated with breast cancer, in a clinical specimen.
Cancer antigen 15-3 (CA15-3) IVD, kit, enzyme immunoassay (EIA)
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of cancer antigen 15-3 (CA15-3), a marker commonly associated with breast cancer, in a clinical specimen using an enzyme immunoassa...
Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
A collection of reagents and other associated materials intended for the qualitative and/or quantitative detection of mRNA expression and/or determination of the gene mutation status of multiple genes associated with cancer in a clinical specimen, using a n...
Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
A collection of reagents and other associated materials intended for the qualitative and/or quantitative detection of mRNA expression and/or determination of the gene mutation status of multiple genes associated with cancer in a clinical specimen, to predic...
Cancer antigen 125 (CA125) IVD, calibrator
A material which is used to establish known points of reference for an assay intended to be used for the qualitative and/or quantitative detection of cancer antigen 125 (CA125), a marker commonly associated with ovarian cancer, in a clinical specimen.
Cancer antigen 125 (CA125) IVD, control
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of cancer antigen 125 (CA125), a marker commonly associated with ovarian cancer, in a clinical specimen.
Cancer/tumour-associated aneuploidy IVD, probe
A defined piece of single-stranded nucleic acid which is used to identify specific complementary-sequence nucleic acid molecules in an assay intended to evaluate a clinical specimen to diagnose, monitor or predict one or multiple acquired aneuploidies assoc...
Cancer antigen 15-3 (CA15-3) IVD, calibrator
A material which is used to establish known points of reference for an assay intended to be used for the qualitative and/or quantitative detection of cancer antigen 15-3 (CA15-3), a marker commonly associated with breast cancer, in a clinical specimen.
Cancer antigen 19-9 (CA19-9) IVD, kit, enzyme immunoassay (EIA)
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of cancer antigen 19-9 (CA19-9) in a clinical specimen, using an enzyme immunoassay (EIA) method. CA19-9 is typically used as a mar...
Colorectal cancer genotyping IVD, kit, nucleic acid technique (NAT)
A collection of reagents and other associated materials intended to be used to evaluate a clinical specimen to diagnose, monitor or predict colorectal cancer, and/or select treatment options and/or monitor the response to cancer therapy, based on multiple d...
Prostate cancer gene 3/prostate specific antigen (PCA3/PSA) mRNA expression IVD, kit, nucleic acid technique (NAT)
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of mRNA expression of the prostate cancer gene 3 (PCA3) and the gene coding for the prostate specific antigen associated with prost...
Cancer antigen 125 (CA125) IVD, kit, enzyme immunoassay (EIA)
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of cancer antigen 125 (CA125), a marker commonly associated with ovarian cancer, in a clinical specimen using an enzyme immunoassay...
Cancer antigen 15-3 (CA15-3) IVD, kit, enzyme immunohistochemistry
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of cancer antigen 15-3 (CA15-3), a marker commonly associated with breast cancer, in a clinical specimen using an enzyme immunohist...
Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
A collection of reagents and other associated materials intended for the qualitative and/or quantitative detection of mRNA expression and/or determination of the gene mutation status of multiple genes associated with cancer in a clinical specimen, using a n...
Fibroblast growth factor receptor (FGFR) gene mutation IVD, kit, nucleic acid technique (NAT)
A collection of reagents and other associated materials intended to be used to help select cancer treatment options and/or monitor the response to cancer therapy by determining the mutation status of the fibroblast growth factor receptor (FGFR) gene, using ...
Prostate cancer gene 3/prostate specific antigen (PCA3/PSA) mRNA expression IVD, control
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of mRNA expression of the prostate cancer gene 3 (PCA3) and the gene coding for the prostate specific antigen associated wit...
Cancer antigen 125 (CA125) IVD, reagent
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of cancer antigen 125 (CA125), a marker commonly associated with ovarian cancer,...
Cancer antigen 15-3 (CA15-3) IVD, reagent
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of cancer antigen 15-3 (CA15-3), a marker commonly associated with breast cancer...
Her2/neu/erbB2 gene mutation IVD, probe
A defined piece of single-stranded nucleic acid which is used to identify specific complementary-sequence nucleic acid molecules in an assay intended to be used to evaluate a clinical specimen to diagnose, monitor or predict genetic mutations (e.g., duplica...
Prostate cancer gene 3/prostate specific antigen (PCA3/PSA) mRNA expression IVD, probe
A defined piece of single-stranded nucleic acid which is used to identify specific complementary-sequence nucleic acid molecules in an assay intended to be used for the qualitative and/or quantitative detection of mRNA expression of the prostate cancer gene...
Prostate cancer gene 3/prostate specific antigen (PCA3/PSA) mRNA expression IVD, reagent
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of mRNA expression of the prostate cancer gene 3 (PCA3) and the gene coding for ...